Occupational exposure to dibutyl phthalate among manicurists

Journal of Occupational and Environmental Medicine

Volumn 50, Issue 6, 2008, Pages 705-711

  Kwapniewski, Rachel ^a   Kozaczka, Sarah ^a   Hauser, Russ ^b   Silva, Manori J ^c   Calafat, Antonia M ^c   Duty, Susan M ^a,b  

^a SIMMONS COLLEGE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; PHTHALIC ACID DIBUTYL ESTER; PLASTICIZER;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLOVE; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; METABOLITE; OCCUPATIONAL EXPOSURE; URINALYSIS; WORKPLACE; AIR CONDITIONING; AIR POLLUTANT; COSMETIC INDUSTRY; ENVIRONMENTAL MONITORING; PROTECTIVE CLOTHING; STATISTICS; URINE; UTILIZATION REVIEW;

RATTUS;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; BEAUTY CULTURE; DIBUTYL PHTHALATE; ENVIRONMENTAL MONITORING; GLOVES, PROTECTIVE; HUMANS; OCCUPATIONAL EXPOSURE; PLASTICIZERS; PROTECTIVE CLOTHING; VENTILATION;

EID: 58549116436     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181651571     Document Type: Article

References (46)

1. ATSDR. Toxicological profile for diethyl phthalate (DEP). Atlanta, GA: Agency for Toxic Substances and Disease Registry; 1995. Available at: www.atsdr.cdc.gov/toxprofiles. Accessed June 23, 2005.
2. ATSDR. Toxicological profile for Di-nbutyl Phthalate (DBP). Atlanta, GA: Agency for Toxic Substances and Disease Registry; 2001. Available at: www.atsdr.cdc.gov/toxprofiles. Accessed June 23, 2005.
3. ATSDR. Toxicological profile for di(2-ethylhexyl)phthalate (DEHP). Atlanta, GA: Agency for Toxic Substances and Disease Registry; 2002. Available at: www.atsdr.cdc.gov/toxprofiles. Accessed June 23, 2005.
4. CDC. Third National Report on Human Exposure to Environmental Chemicals. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Environmental Health, Division of Laboratory Sciences; 2005. Available at: http://www.cdc.gov/exposurereport/3rd/pdf/thirdreport.pdf. Accessed April 30, 2006.
5. Hubinger JC, Havery DC. Analysis of consumer cosmetic products for phthalate esters. J Cosmet Sci. 2006;57:127-137.
6. Environmental Working Group (EWG). Beauty Secrets. Washington, DC: EWG; 2000. Available at: http://www.ewg.org/reports/beautysecrets.html. Accessed December 19, 2006.
7. Houlihan J, Brody C, Schwan B. Not too pretty: phthalates, beauty products & the FDA. Environmental Working Group, Coming Clean and Health Care without Harm; 2002. Available at: www.nottoopretty.org. Accessed June 23, 2005.
8. Koo HJ, Lee BM. Estimated exposure to phthalates in cosmetics and risk assessment. J Toxicol Environ Health. 2004;67: 1901-1914.
9. Hauser R, Calafat AM. Phthalates and human health. Occup Environ Med. 2005;62:806-818.
10. Koch HM, Müller J, Wittassek M, Angerer J. Influence of alimentary abstinence on body burden to phthalates. Epidemiology. 2006:S300.
11. Adibi JJ, Perera FP, Jedrychowski W, et al. Prenatal exposures to phthalates among women in New York City and Krakow, Poland. Environ Health Perspect. 2003;111:1719-1722.
12. Duty SM, Ackerman RM, Calafat AM, Hauser RH. Personal care product use predicts urinary concentrations of some phthalate monoesters. Environ Health Perspect. 2005;113:1530-1535.
13. Pan G, Hanaoka T, Yoshimura M, et al. Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): a cross-sectional study in China. Environ Health Perspect. 2006;114: 1643-1648.
14. Computerized Research and Development (CRD). Mailing list of professionals licensed by state. Computerized Research and Development, Inc; 2006. Available at: www.computerizedresearch.com/lists/manicurist.htm. Accessed June 23, 2005.
15. MBRC. Division of Professional Licensure. Boston, MA: Massachusetts Board of Registration of Cosmetologists; 2005. Available at: http://www.state.ma.us/reg/boards/hd/default.htm. Accessed July 3, 2005.
16. Nails Magazine. NAILS Magazine 2005-2006 Big Book; 2006. Available at: http://www.nailsmag.com/pdfView. aspx?pdfName=2006-NailTechnician Demographics.pdf. Accessed December 7, 2006.
17. NIOSH. Health Hazard Evaluation. Report No. 90-048. Atlanta, GA: National Institute of Occupational Health; 1992. Available at: http://www.cdc.gov/niosh/hhe/reports. Accessed on December 19, 2006.
18. NIOSH. Health Hazard Evaluation. Report No. 92-128. Atlanta, GA: National Institute of Occupational Health; 1992. Available at: http://www.cdc.gov/niosh/hhe/reports. Accessed on December 19, 2006.
19. Blount BC, Milgram KE, Silva MJ, et al. Quantitative detection of eight phthalate metabolites in human urine using HPLCAPCI-MS/MS. Anal Chem. 2000;72: 4127-4134.
20. Barr DB, Silva MJ, Kato K, et al. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. Environ Health Perspect. 2003;111:1148-1151.
21. Li LH, Jester WF, Orth JM. Effects of relatively low levels of mono-(2-ethylhexyl) phthalate on cocultured Sertoli cells and gonocytes from neonatal rats. Toxicol Appl Pharmacol. 1998;153:258-265.
22. Wine R, Li LH, Barnes LH, Gulati DK, Chapin RE. Reproductive toxicity of di-nbutyl phthalate in a continuous breeding protocol in Sprague-Dawley rats. Environ Health Perspect. 1997;105:102-107.
23. Mylchreest E, Cattley RC, Foster PMD. Male reproductive tract malformations in rats following gestational and lactational exposure to di(n-butyl) phthalate: an antiandrogenic mechanism? Toxicol Sci. 1998;43:47-60.
24. Mylchreest E, Wallace DG, Cattley RC, Foster PMD. Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to di(nbutyl) phthalate during late gestation. Toxicol Sci. 2000;55:143-151.
25. Mylchreest E, Sar M, Wallace DG, Foster PMD. Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di(n-butyl) phthalate. Reprod Toxicol. 2002;16:19-28.
26. CERHR. NTP-CERHR Expert Panel Report on Di-n-Butyl Phthalate. Research Triangle Park, NC: National Toxicology Program, Center for Evaluation of Risks to Human Reproduction; 2000. Available at: http://cerhr.niehs.nih.gov/ news/phthalates/DBP-Monograph-Final.pdf. Accessed November 4, 2005.
27. Ema M, Miyawaki E, Kawashima K. Further evaluation of developmental toxicity of di-n-butyl phthalate following administration during late pregnancy in rats. Toxicol Lett. 1998;98:87-93.
28. Ema M, Miyawaki E, Kawashima K. Developmental effects of plasticizer butyl benzyl phthalate after a single administration in rats. J Appl Toxicol. 1999;19: 357-365.
29. Ema M, Miyawaki E, Kawashima K. Effects of dibutyl phthalate on reproductive function in pregnant and pseudopregnant rats. Reprod Toxicol. 2000;14:13-19.
30. Saillenfait AM, Payan JP, Fabry JP, et al. Assessment of the developmental toxicity, metabolism, and placental transfer of Di-nbutyl phthalate administered to pregnant rats. Toxicol Sci. 1998;45:212-224.
31. Duty SM, Silva MJ, Barr DB, et al. Phthalate exposure and human semen parameters. Epidemiology. 2003;14:269-277.
32. Hauser R, Meeker JD, Duty S, Silva MJ, Calafat AM. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology. 2006;17:682-691.
33. Swan SH, Main KM, Liu F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113: 1056-1061.
34. Boeniger MF, Lowry LK, Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J. 1993;54:615-627.
35. Tremaine LM, Quebbemann AJ. The renal handling of terephthalic acid. Toxicol Appl Pharmacol. 1985;77:165-174.
36. Silva MJ, Slakman AR, Reidy JA, et al. Analysis of human urine for fifteen phthalate metabolites using automated solid-phase extraction. J Chromatogr B. 2004;805:161-167.
37. Kato K, Silva MJ, Needham LL, Calafat AM. Determination of 16 phthalate metabolites in urine using automated sample preparation and on-line preconcentration/high-performance liquid chromatography/tandem mass spectrometry. Anal Chem. 2005;77:2985-2991.
38. Calafat AM, Silva MJ, Reidy JA, et al. Mono-3-carboxypropyl phthalate, a metabolite of di-n-octyl phthalate. J Toxicol Environ Health. 2006;69:215-227.
39. Elsisi AE, Carter DE, Sipes IG. Dermal absorption of phthalate diesters in rats. Fundam Appl Toxicol. 1989;12:70-77.
40. Hoppin JA, Brock JW, Davis BJ, Baird DD. Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ Health Perspect. 2002;111: 515-518.
41. Fromme H, Bolte G, Koch HM, et al. Occurrence and daily variation of phthalate metabolites in the urine of an adult population. Int J Hyg Environ Health. 2007;210:21-33.
42. Hauser R, Meeker JD, Park S, Silva MJ, Calafat AC. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect. 2004;112:1734-1740.
43. NIH. Outreach Notebook for the Inclusion, Recruitment, and Retention of Women and Minority Subjects in Clinical Research. Bethesda, MD: National Institute of Health; 2002. Available at: http://orwh.od.nih.gov/inclusion/ outreach.pdf. Accessed December 10, 2006.
44. Marquez MA, Muhs JM, Tosomeen A, Riggs BL, Melton LJ. Costs and strategies in minority recruitment for osteoporosis research. J Bone Miner Res. 2003; 18:3-8.
45. Barata PC, Gucciardi E, Ahmad F, Stewart DE. Cross-cultural perspectives on research participation and informed consent. Soc Sci Med. 2006;62:479-490.
46. Brown BA, Long HL, Weitz T, Milliken N. Challenges of recruitment: focus groups with research study recruiters. Women Health. 2000;31:153-166.